Doktorate an Medizinischen Universitäten: gewonnene oder verlorene Zeit? Stefan Boehm Abteilung für Neurophysiologie und pharmakologie Zentrum für Physiologie und Pharmakologie Curriculumdirektor für die Doktoratsstudien
Whining PhD students are nothing new, but there seem to be genuine problems with iththe system that tproduces research hdoctorates t (the practical l professional doctorates in fields such as law, business and medicine have a more obvious value). (The Economist, Dec 2010) PhD programmes in the sciences still overemphasize the academic track and actively devalue other career paths. (Nature 472, April 2011)
N094 N790 Science as profession Science in profession
Equivalence of N094 and N790
Qualification profile N094
Qualification profile N790
Courses and ECTS credits N094 N790
Propedeutics general knowledg ge and transfera able skills
Doctoral curricula, students, and graduates (since 2004) 936 doctoral students, 184 doctoral graduates Doctoral Program of Medical Sciences 86 students, 109 graduates PhD Program 501 students, 70 graduates Doctoral Program of Applied Medical Sciences 386 students, 5 graduates number of thes sis submissions pe er month 10 8 6 4 2 0 2007 2008 2009 2010 2011 month number of the esis defenses per 10 8 6 4 2 0 2007 2008 2009 2010 2011
Doctoral students Medical Sciences PhD Applied Medical Sciences International Austrian 0 20 40 60 80 100 % of students 0 20 40 60 80 100 % of students 0 20 40 60 80 100 % of students Non-Medical Medical 0 20 40 60 80 100 % of students 0 20 40 60 80 100 % of students 0 20 40 60 80 100 % of students
6 Doctoral programs funded by Molecular Drug Targets
CCHD Cell Communication in Health and Disease A doctoral programme supported by the Austrian Science Fund (FWF), the Medical University of Vienna (MUW), and the Center for Molecular Medicine (CeMM) Coordinator: Sylvia Knapp
priority areas of research at the MUW Allergology / Immunology / Infectious diseases Oncology Neuroscience Vascular Biology Organ failure and replacement Inflammation Public health Basic medical and diagnostic research Intensive care research Metabolism (and nutrition) Cell Communication in Health and Disease
topics and supervisors of CCHD Immunology Erika Jensen-Jarolim: immunity towards oral antigens Sli Sylvia Knapp: innate immunity and bacterial infection Hannes Stockinger: T cell activation in real-time Giulio Superti-Furga: signalling pathway proteomics Vascular Biology Margarethe Geiger: serine proteases and coagulation Dontscho Kerjaschki: lymphatic endothelial cells Christine Mannhalter: pathogenic mechanisms in thrombotic diseases Neurobiology Inflammation Stefan Boehm: Hans Lassmann: mechanisms of presynaptic modulation pathogenic mechanisms in multiple sclerosis Michael Freissmuth: GPCRs and neurotransmitter transporters Thomas Klausberger: molecular machineries in cortical networks Werner Sieghart: GABA A receptor structure and function Cell Communication in Health and Disease Thomas Stulnig: mechanisms of adipose tissue inflammation Oswald Wagner: inflammation in atherosclerosis
major assets of CCHD internationally visible graduate programme multidisciplinary approach to study cell communication as basis for improved understanding of disease mechanisms and drug target identification/validation network of open laboratories with daily interactions training of excellent graduate students in medically relevant signal transduction research and in a broad range of advanced techniques integrated interdisciplinary teaching programme international exposure of the graduate students Cell Communication in Health and Disease
application-oriented further training (propedeutics) GSP and Ethics in Science (Ernst Singer, chairman of the Ethics Committee at the MUW) research in the pharmaceutical industry, GMP, GLP (Peter Turecek, senior dirctor R&D, Baxter, Austria) GCP and medical statistics (Sandor Fritsch,,g global director statistics, Baxter, Austria) project management (Rudolf Widman, CEO of Austrian Orphan Pharmaceuticals) intellectual property rights (Harald Nemec, European Patent Attorney Company) scientific English, communication and funding (Edda Fiebiger, Children s Hospital, Boston, USA) basics of bioinformatics (Jacques Colinge, CeMM) basic infection biology (Sylvia Knapp, CeMM)
For further information see www.phd-cchd.at
previous doctoral students of the neuropharmacology group Nina Vartian Ursula Unterberger Thomas Scholze Stefan Lechner Hanna Edelbauer Simon Hussl Mario Dorostkar Klaus Schicker Kristina Kosenburger Felicia Klinger AOP Orphan Pharmaceuticals Clinical Institute of Neurology; AKH Baxter Austria Max-Delbrück-Center for Molecular Medicine, Berlin KAV Der Drink Center for Neuropathology, Ludwig-Maximilians-Univ. München Center for Physiology and Pharmacology, Medical Univ. Vienna Agneter Pharmaconsulting Clinic for Radiology, AKH aop orphan